Company / Return on Assets (ROA)
SUTRO BIOPHARMA, INC. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-130.8%
FY2025
5-year range
-130.8% / -16.3%
FY2021-FY2025
Trend
-325.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -325% YoY in FY2025, a notable deviation from the 7-year average annual change of -318%.
Based on SEC 10-K filings.
-130.8% in FY2025 with a 5-year CAGR of -121.9%.
Declined from -22.4% to -130.8% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -101.6pp
- 5-Year Change
- -121.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 325.0% year-over-year.
- Peak return on assets (roa) was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -130.8% | -325.0% |
| FY2024 | -30.8% | -37.3% |
| FY2023 | -22.4% | +23.5% |
| FY2022 | -29.3% | -79.4% |
| FY2021 | -16.3% | -82.3% |
| FY2020 | -9.0% | +28.8% |
| FY2019 | -12.6% | -1756.6% |
| FY2018 | 0.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026